Bon Natural Life Ltd
NASDAQ:BON
Bon Natural Life Ltd
Bon Natural Life Ltd. engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants which are widely used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company is headquartered in Xi'An, Shaanxi and currently employs 93 full-time employees. The company went IPO on 2021-06-24. The firm's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.
Bon Natural Life Ltd. engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants which are widely used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company is headquartered in Xi'An, Shaanxi and currently employs 93 full-time employees. The company went IPO on 2021-06-24. The firm's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.
Revenue Growth: Bon Natural Life reported 2022 revenue of $29.9 million, up 17.3% year-over-year, driven by higher average selling prices and increased volumes in key categories.
Profitability: Net income rose 35.4% to $6.2 million and gross profit increased 32.5% to $9.4 million, reflecting improved sales mix and pricing.
Product & Capacity Expansion: The company is completing its Yumen Plant, expecting a 200% increase in production capacity and up to 150% revenue growth from the new facility.
New Products: Bon introduced innovative products like FeatherPure for female care and a broccoli-based probiotic drink, aiming to tap into new growth areas.
Overseas Sales: Overseas revenue dropped due to supply chain disruptions and port congestion, but management expects a rebound in 2023.
Accounts Receivable: The company saw a rise in receivables but reported no payment issues or bad debt as of January 2023.
